Published October 21, 2005 | Version v1
Journal article

Role of a novel dual flavin reductase (NR1) and an associated histidine triad protein (DCS-1) in menadione-induced cytotoxicity

  • 1. Department of Genetics and Genomic Biology, Hospital for Sick Children, Toronto, Ont. (Canada)
  • 2. Graduate Program in Neuroscience, Department of Psychiatry and Brain Research Centre, University of British Columbia, Vancouver, BC V6T 1Z3 (Canada)

Description

Microsomal cytochrome P450 reductase catalyzes the one-electron transfer from NADPH via FAD and FMN to various electron acceptors, such as cytochrome P450s or to some anti-cancer quinone drugs. This results in generation of free radicals and toxic oxygen metabolites, which can contribute to the cytotoxicity of these compounds. Recently, a cytosolic NADPH-dependent flavin reductase, NR1, has been described which is highly homologous to the microsomal cytochrome P450 reductase. In this study, we show that over-expression of NR1 in human embryonic kidney cells enhances the cytotoxic action of the model quinone, menadione. Furthermore, we show that a novel human histidine triad protein DCS-1, which is expressed together with NR1 in many tissues, can significantly reduce menadione-induced cytotoxicity in these cells. We also show that DCS-1 binds NF1 and directly modulates its activity. These results suggest that NR1 may play a role in carcinogenicity and cell death associated with one-electron reductions

Additional details

Identifiers

DOI
10.1016/j.bbrc.2005.08.129;
PII
S0006-291X(05)01784-5;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
336
Journal Issue
2
Journal Page Range
p. 565-571
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.